Keith Baker - Net Worth and Insider Trading
Keith Baker Net Worth
The estimated net worth of Keith Baker is at least $10,550 dollars as of 2024-05-10. Keith Baker is the CFO of Kineta Inc and owns about 16,880 shares of Kineta Inc (KA) stock worth over $10,550. Details can be seen in Keith Baker's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Keith Baker has not made any transactions after 2023-09-18 and currently still holds the listed stock(s).
Transaction Summary of Keith Baker
Keith Baker Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Keith Baker owns 2 companies in total, including Yumanity Therapeutics Inc (YMTX) , and Kineta Inc (KA) .
Click here to see the complete history of Keith Baker’s form 4 insider trades.
Insider Ownership Summary of Keith Baker
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| YMTX | Yumanity Therapeutics Inc | 2022-12-16 | Chief Financial Officer |
| KA | Kineta Inc | 2023-09-18 | Chief Financial Officer |
Keith Baker Latest Holdings Summary
Keith Baker currently owns a total of 1 stock. Keith Baker owns 16,880 shares of Kineta Inc (KA) as of September 18, 2023, with a value of $10,550.
Latest Holdings of Keith Baker
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KA | Kineta Inc | 2023-09-18 | 16,880 | 0.63 | 10,550 |
Holding Weightings of Keith Baker
Keith Baker Form 4 Trading Tracker
According to the SEC Form 4 filings, Keith Baker has made a total of 2 transactions in Kineta Inc (KA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Kineta Inc is the acquisition of 5,000 shares on September 18, 2023, which cost Keith Baker around $10,650.
Insider Trading History of Keith Baker
- 1
Keith Baker Trading Performance
GuruFocus tracks the stock performance after each of Keith Baker's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Keith Baker is 20.96%. GuruFocus also compares Keith Baker's trading performance to market benchmark return within the same time period. The performance of stocks bought by Keith Baker within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Keith Baker's insider trading performs compared to the benchmark.
Performance of Keith Baker
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 19.33 |  | | | | |
| Relative Return to S&P 500(%) | 19.8 | | | | | |
Keith Baker Ownership Network
Keith Baker Owned Company Details
What does Yumanity Therapeutics Inc do?
Who are the key executives at Yumanity Therapeutics Inc?
Keith Baker is the Chief Financial Officer of Yumanity Therapeutics Inc. Other key executives at Yumanity Therapeutics Inc include director & Chief Executive Officer Shawn Iadonato , Chief Scientific Officer Thierry Guillaudeux , and General Counsel Pauline Kenny .
Yumanity Therapeutics Inc (YMTX) Insider Trades Summary
Over the past 18 months, Keith Baker made no insider transaction in Yumanity Therapeutics Inc (YMTX). Other recent insider transactions involving Yumanity Therapeutics Inc (YMTX) include a net sale of 10,890 shares made by Richard Peters , a net sale of 3,116 shares made by Michael D Wyzga , and a net sale of 3,116 shares made by Devin Whittemore Smith .
In summary, during the past 3 months, insiders sold 0 shares of Yumanity Therapeutics Inc (YMTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 19,098 shares of Yumanity Therapeutics Inc (YMTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 19,098 shares.
Yumanity Therapeutics Inc (YMTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Yumanity Therapeutics Inc Insider Transactions
Keith Baker Mailing Address
Above is the net worth, insider trading, and ownership report for Keith Baker. You might contact Keith Baker via mailing address: C/o Kineta, Inc., 219 Terry Ave. N., Suite 300, Seattle Wa 98109.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
